| 000 | 01133 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515230612.0 | ||
| 264 | 0 | _c20101005 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a2040-3429 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSoares, Holly D | |
| 245 | 0 | 0 |
_aThe use of mechanistic biomarkers for evaluating investigational CNS compounds in early drug development. _h[electronic resource] |
| 260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cJul 2010 |
||
| 300 |
_a795-801 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers, Pharmacological _xmetabolism |
| 650 | 0 | 4 |
_aCentral Nervous System Agents _xpharmacology |
| 650 | 0 | 4 |
_aClinical Trials, Phase I as Topic _xmethods |
| 650 | 0 | 4 |
_aClinical Trials, Phase II as Topic _xmethods |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
| 650 | 0 | 4 |
_aTranslational Research, Biomedical _xmethods |
| 773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 11 _gno. 7 _gp. 795-801 |
|
| 999 |
_c19920343 _d19920343 |
||